SCHEMBL8070540

SCHEMBL8070540

O=C1Cc2ccccc2C(=O)N1CCCCCCCCCCCO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.61
ALDH1A1 P00352 3/20 0.61
APAF1 O14727 3/20 0.61
MAPT P10636 3/20 0.61
GAA P10253 3/20 0.61
RAB9A P51151 2/20 0.61
BLM P54132 2/20 0.61
CASP1 P29466 1/20 0.61
CASP7 P55210 1/20 0.61
HSD17B10 Q99714 1/20 0.61
MEN1 O00255 5/20 0.56
HPGD P15428 1/20 0.56
HDAC8 Q9BY41 4/20 0.53
HDAC3 O15379 3/20 0.53
HDAC4 P56524 3/20 0.53
HDAC1 Q13547 3/20 0.53
HDAC7 Q8WUI4 3/20 0.53
HDAC2 Q92769 3/20 0.53
HDAC10 Q969S8 3/20 0.53
HDAC11 Q96DB2 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11283988 0.94 KMT2A (0.64) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL11280189 0.88 KMT2A (0.68) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL11852813 0.85 KMT2A (0.61) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL8019454 0.84 KMT2A (0.53) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL9381432 0.84 KMT2A (0.62) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL14560538 0.84 KMT2A (0.62) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL11226364 0.82 KMT2A (0.64) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL11241465 0.82 KMT2A (0.64) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL11839322 0.82 KMT2A (0.64) KMT2AALDH1A1APAF1MAPTGAA
SCHEMBL8077147 0.82 KMT2A (0.57) KMT2AALDH1A1APAF1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 EP claimed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 EP claimed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 WO claimed
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 EP disclosed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 EP disclosed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 WO disclosed